12M+
people worldwide suffer from corneal blindness and need a corneal transplant.
98%
Of those with corneal blindness live in low-and middle-income countries (LMICs)
>98%
Of those who need a corneal transplant in LMICs will not receive one
#1
Corneal blindness is the leading cause of blindness for those under 50 in India.
About
KeraX, the impact-first venture lab arm of KeraLink International focuses on sustainable innovations for corneal and ocular diseases affecting low and middle income countries globally. KeraX makes select seed investments and develops in house ventures targeting underinvested gaps in the treatment landscape.
.png)
Our Process
Discover
We identify technologies with the potential to transform access to vision health.
Develop
Each opportunity undergoes a thorough validation process to assess its clinical relevance, technical feasibility and market potential.
Deploy
We accelerate an innovation’s path into either spinout companies or strategic licensing agreements, leveraging our global network of eyecare partners.
PEN Strategy
Our comprehensive approach covers Prevention, Early detection, and Novel treatments, and this PEN strategy seeks to rewrite the future of global health eyecare.
Our Partners
